Takeda Pharma sedol B01DRX9 US's ticker is and the CUSIP is J8129E108. A total of 1 filers reported holding Takeda Pharma sedol B01DRX9 US in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $15,000 | -58.3% | 321 | -61.3% | 0.00% | -60.0% |
| Q3 2015 | $36,000 | +12.5% | 830 | +25.8% | 0.01% | 0.0% |
| Q2 2015 | $32,000 | +220.0% | 660 | +230.0% | 0.01% | +400.0% |
| Q1 2015 | $10,000 | +11.1% | 200 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $9,000 | -10.0% | 200 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $10,000 | 0.0% | 200 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $10,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crow Point Partners, LLC | 200 | $10,000 | 0.00% |